Characterization of human non-small cell lung cancer (NSCLC) cell lines for expression of MHC, co-stimulatory molecules and tumor-associated antigens

被引:45
作者
Wroblewski, JM
Bixby, DL
Borowski, C
Yannelli, JR
机构
[1] Univ Kentucky, Coll Med, Markey Canc Ctr, Div Hematol & Oncol, Lexington, KY 40536 USA
[2] Univ Kentucky, Coll Pharm, Dept Med Chem & Pharmaceut, Lexington, KY 40536 USA
[3] Harvard Univ, Sch Med, Dept Immunol, Boston, MA USA
关键词
non-small cell lung cancer; CD80; CD86; cytotoxic T cells; immunotherapy;
D O I
10.1016/S0169-5002(01)00210-0
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A panel of 31 long-term non-small cell lung cancer (NSCLC) cell lines was examined for the expression of protein and/or mRNA transcripts for 11 distinct immune response related molecules or tumor associated antigens (TAA). To assess whether cytokine stimulation might up-regulate expression of the genes of interest, cells were cultured in 500 U/ml of gamma-interferon (gamma -IFN) for 48-72 h prior to analysis. Major histocompatibility complex (MHC) Class I antigens were detected by indirect immunofluorescence and were constitutively expressed on all of the cell lines. The average of the mean fluorescence intensity (MFI) measured 222 +/- 22. gamma -IFN stimulation produced a significant increase to 482 +/- 36. For MHC Class II only 7/31 cell lines (23%) exhibited constitutive expression, while gamma -IFN treatment had a dramatic effect and yielded 18/31 (58%) positive cell lines. The co-stimulatory molecules CD80 and CD86 were examined by direct immunofluorescence for cell surface expression and RT-PCR amplification for mRNA. CD80 protein was not detected at all, while an insignificant percentage of cells were positive (mean 2%) for CD86 in all cell lines tested. gamma -IFN had no apparent effect on CD80 or CD86 protein expression. Constitutive CD80 or CD86 mRNA levels were observed in 45 and 61% of the NSCLC lines, respectively. These percentages increased to 77% and 90% with gamma -IFN. Cell surface phenotypic analysis for TAA revealed positive populations in 28/31 cell lines (90%) for Her-2/neu, 18/31 (58%) for CEA and 8/31 (26%) for GD-2, with gamma -IFN having no effect. After gamma -IFN stimulation, RT-PCR amplification for Mage-1, -2, -3 and WT-1 detected mRNA in 33%, 33%, 44% and 70% of the cell lines, respectively. Overall, gamma -IFN stimulation led to the up-regulation of MHC Class I molecules and class 11 molecules as well as CD80 and CD86 mRNA transcripts. This survey represents the first comprehensive analysis of NSCLC cell lines for a variety of molecules that could play an important role in the generation of an NSCLC anti-tumor CD8 + cytotoxic T lymphocyte (CTL) response. (C) 2001 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:181 / 194
页数:14
相关论文
共 54 条
[1]  
AMIN KM, 1995, AM J PATHOL, V146, P344
[2]   CONSTITUTIVE EXPRESSION OF B7 RESTORES IMMUNOGENICITY OF TUMOR-CELLS EXPRESSING TRUNCATED MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-II MOLECULES [J].
BASKAR, S ;
OSTRANDROSENBERG, S ;
NABAVI, N ;
NADLER, LM ;
FREEMAN, GJ ;
GLIMCHER, LH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (12) :5687-5690
[3]   INTERLEUKIN-2 WITH EXVIVO ACTIVATED KILLER-CELLS - THERAPY OF ADVANCED NON-SMALL-CELL LUNG-CANCER [J].
BERNSTEIN, ZP ;
GOLDROSEN, MH ;
VAICKUS, L ;
FRIEDMAN, N ;
WATANABE, H ;
RAHMAN, R ;
PARK, J ;
ARBUCK, SG ;
SWEENEY, J ;
VESPER, DS ;
TAKITA, H ;
ZEFFREN, J ;
DENNIN, RA ;
FOON, KA .
JOURNAL OF IMMUNOTHERAPY, 1991, 10 (05) :383-387
[4]  
Bixby DL, 1998, INT J CANCER, V78, P685, DOI 10.1002/(SICI)1097-0215(19981209)78:6<685::AID-IJC4>3.3.CO
[5]  
2-3
[6]  
Chamberlain RS, 1996, CANCER RES, V56, P2832
[7]   TUMOR IMMUNOGENICITY DETERMINES THE EFFECT OF B7 COSTIMULATION ON T-CELL-MEDIATED TUMOR-IMMUNITY [J].
CHEN, LP ;
MCGOWAN, P ;
ASHE, S ;
JOHNSTON, J ;
LI, YW ;
HELLSTROM, I ;
HELLSTROM, KE .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 179 (02) :523-532
[8]   COSTIMULATION OF T-CELLS FOR TUMOR-IMMUNITY [J].
CHEN, LP ;
LINSLEY, PS ;
HELLSTROM, KE .
IMMUNOLOGY TODAY, 1993, 14 (10) :483-486
[9]   COSTIMULATION OF ANTITUMOR IMMUNITY BY THE B7 COUNTERRECEPTOR FOR THE LYMPHOCYTE-T MOLECULES CD28 AND CTLA-4 [J].
CHEN, LP ;
ASHE, S ;
BRADY, WA ;
HELLSTROM, I ;
HELLSTROM, KE ;
LEDBETTER, JA ;
MCGOWAN, P ;
LINSLEY, PS .
CELL, 1992, 71 (07) :1093-1102
[10]  
CHERESH DA, 1986, CANCER RES, V46, P5112